Skip to main content
Terug
Watch Compare

Milestone Pharmaceuticals Inc.

Datakwaliteit: 83%
MIST
Nasdaq Manufacturing Chemicals
€ 1,95
▲ € 0,17 (9,27%)
Marktkapitalisatie: 228,86 M
Prijs
€ 1,95
Marktkapitalisatie
228,86 M
Dagbereik
€ 1,80 — € 2,17
52-Weeksbereik
€ 0,69 — € 3,06
Volume
10.245.147
Openen € 1,80
50D / 200D Gem.
€ 1,65
17,88% above
50D / 200D Gem.
€ 1,88
3,46% above

Quick Summary

Belangrijkste Punten

Debt/Equity of 2,74 — high leverage
Negative free cash flow of -49,34 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-4576,05%
Onder sectorgemiddelde (-51,02%)
ROIC-85,11%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
2,74
Boven sectorgemiddelde (0,33)
Current Ratio8,24
Interest Coverage-16,19

Waardering

PE (TTM)
-3,63
Onder sectorgemiddelde (-1,98)
P/B Ratio11,16
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E -3,6 -2,0
P/B 11,2 5,1
ROE % -4576,1 -51,0
Net Margin % — -150,2
Rev Growth 5Y % — 9,3
D/E 2,7 0,3

ETFs Holding This Stock

SURI logo SURI Simplify Propel Opportunities ETF
8,20% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -63,06 M
ROE -4576,05% ROA -93,30%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -49,34 M
ROIC -85,11% FCF Growth (3Y) N/A
Safety
Debt / Equity 2,74 Current Ratio 8,24
Interest Coverage -16,19 Asset Turnover N/A
Working Capital 76,15 M Tangible Book Value 20,50 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3,63 Forward P/E N/A
P/B Ratio 11,16 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -21,56%
Market Cap 228,86 M Enterprise Value 238,38 M
Per Share
EPS (Diluted TTM) -0,75 Revenue / Share N/A
FCF / Share -0,42 OCF / Share -0,42
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 78,25%
SBC-Adj. FCF -54,65 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -63,06 M -41,52 M -59,69 M -58,39 M -42,85 M
EPS (Diluted) -0,75 -0,67 -1,39 — -1,02
Gross Profit — — — — —
Operating Income -62,14 M -42,10 M -61,10 M -59,64 M -43,07 M
EBITDA — — — — —
R&D Expenses 18,11 M 14,36 M 31,05 M 39,83 M 38,67 M
SG&A Expenses — — — — —
D&A 114.000,0 105.000,0 92.000,0 89.000,0 93.000,0
Interest Expense 3,84 M 3,58 M 2,55 M — —
Income Tax — — — — -17.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 113,56 M 75,50 M 75,23 M 74,48 M 119,85 M
Total Liabilities 71,79 M 62,35 M 58,46 M 8,14 M 7,25 M
Shareholders' Equity 41,77 M 13,15 M 16,77 M 66,35 M 112,60 M
Total Debt 57,19 M 53,35 M 49,77 M — —
Cash & Equivalents 73,05 M 25,31 M 13,76 M 7,64 M 114,14 M
Current Assets 111,92 M 73,93 M 73,03 M 71,80 M 118,92 M
Current Liabilities 13,98 M 8,13 M 7,23 M 6,14 M 6,78 M